Kommentar
CRC screening with sigmoidoscopy extends life by 110 d; other cancer screening tests do not extend life
Annals of Internal Medicine · 2024
DOI: 10.7326/j23-0112 ↗Kurz gefasst
Kommentar in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Thomas F Imperiale. Beteiligte Einrichtung: Indiana University School of Medicine, Indianapolis, Indiana, USA (T.F.I.). Hauptthemen laut MEDLINE: Colorectal Neoplasms, Sigmoidoscopy. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Colorectal NeoplasmsSigmoidoscopyHumansColonoscopyEarly Detection of CancerMass ScreeningOccult BloodMeta-Analysis as Topic
Autor:innen und Institutionen
- Indiana University School of Medicine, Indianapolis, Indiana, USA (T.F.I.).
Zitieren
APA
Imperiale, T. F. (2024). CRC screening with sigmoidoscopy extends life by 110 d; other cancer screening tests do not extend life. Annals of Internal Medicine. https://doi.org/10.7326/j23-0112
Vancouver
Imperiale TF. CRC screening with sigmoidoscopy extends life by 110 d; other cancer screening tests do not extend life. Annals of Internal Medicine. 2024. doi:10.7326/j23-0112
BibTeX
@article{Imperiale2024,
author = {Imperiale, Thomas F},
title = {CRC screening with sigmoidoscopy extends life by 110 d; other cancer screening tests do not extend life},
journal = {Annals of Internal Medicine},
year = {2024},
doi = {10.7326/j23-0112}
}
EUVIMED